Cardioverter-defibrillators in hypertrophic cardiomyopathy: a French multicenter study

Back

ESC Premium Access

Cardioverter-defibrillators in hypertrophic cardiomyopathy: a French multicenter study

Session: Risk prediction for sudden cardiac death and ICD treatments

Topic: Automatic implantable cardioverter / defibrillator

Speaker: Mr P. Flechon (Vandoeuvre-Les-Nancy, FR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Mr Pierre-Cyril Flechon

Hospital Brabois of Nancy, Vandoeuvre-Les-Nancy (France)

0 follower

9 more presentations in this session

Targeted next-generation sequencing as a comprehensive test for patients with hypertrophic cardiomyopathy

Speaker: Doctor R. Brugada Terradellas (Salt, ES)

Impact of the timing of coronary angiography in patients with resuscitated out of hospital cardiac arrest on survival

Speaker: Professor F. Beygui (Caen, FR)

Periodic Repolarization Dynamics as risk predictor in patients with Long-QT Syndrome

Speaker: Doctor K. Rizas (Munich, DE)

Periodic Repolarization Dynamics as risk predictor after myocardial infarction: PRD-MI study

Speaker: Doctor K. Rizas (Munich, DE)

Opening a new front in the fight against sudden cardiac death: is it time for near-term prevention?

Speaker: Doctor N. Karam (Paris, FR)

Access the full session

Risk prediction for sudden cardiac death and ICD treatments

Speakers: Mr P. Flechon, Doctor R. Brugada Terradellas, Professor F. Beygui, Doctor K. Rizas, Doctor K. Rizas...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources